CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $139,000 | -73.6% | 35,447 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $527,000 | -76.5% | 35,447 | -60.8% | 0.00% | -77.8% |
Q1 2019 | $2,244,000 | +59.6% | 90,411 | +15.5% | 0.01% | +50.0% |
Q4 2018 | $1,406,000 | -32.7% | 78,296 | +10.2% | 0.01% | -25.0% |
Q3 2018 | $2,088,000 | -73.4% | 71,078 | -58.8% | 0.01% | -75.8% |
Q2 2018 | $7,837,000 | +22.4% | 172,356 | +42.1% | 0.03% | +10.0% |
Q1 2018 | $6,405,000 | -85.3% | 121,302 | -81.1% | 0.03% | -84.8% |
Q4 2017 | $43,704,000 | -36.0% | 642,709 | -22.4% | 0.20% | -38.2% |
Q3 2017 | $68,261,000 | +30.7% | 828,407 | +48.5% | 0.32% | +28.1% |
Q2 2017 | $52,216,000 | +391.0% | 557,680 | +233.9% | 0.25% | +369.8% |
Q1 2017 | $10,635,000 | +244.4% | 167,035 | +140.3% | 0.05% | +211.8% |
Q4 2016 | $3,088,000 | +350.8% | 69,508 | +265.8% | 0.02% | +325.0% |
Q3 2016 | $685,000 | -92.9% | 19,000 | -81.9% | 0.00% | -92.5% |
Q3 2015 | $9,655,000 | -19.2% | 104,991 | -22.8% | 0.05% | -1.9% |
Q2 2015 | $11,954,000 | +4.5% | 136,024 | -11.7% | 0.05% | +3.8% |
Q1 2015 | $11,440,000 | +33547.1% | 154,119 | +25374.2% | 0.05% | – |
Q4 2014 | $34,000 | +25.9% | 605 | 0.0% | 0.00% | – |
Q3 2014 | $27,000 | +8.0% | 605 | 0.0% | 0.00% | – |
Q2 2014 | $25,000 | -40.5% | 605 | 0.0% | 0.00% | – |
Q1 2014 | $42,000 | +16.7% | 605 | +2.5% | 0.00% | – |
Q4 2013 | $36,000 | 0.0% | 590 | 0.0% | 0.00% | – |
Q3 2013 | $36,000 | – | 590 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |